HOBOKEN, N.J. and OAKLAND, Calif., July 14, 2021 /PRNewswire/ -- Health Recovery Solutions, a leading provider of telehealth and remote patient monitoring solutions, today announced a partnership with ...

San Francisco, CA, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Eko, a digital health company applying artificial intelligence (AI) in the fight against heart disease, today announced the U.S. Food and Drug ...

Berkeley, California-based Eko Devices has received FDA clearance for Duo, a smart heart monitor that is a combination of a digital stethoscope and portable electrocardiogram. Duo is intended as a ...

Eko has received FDA clearance for two artificial intelligence algorithms embedded into the healthcare technology company's digital stethoscope to detect serious heart conditions, the company ...

Heart failure with reduced ejection fraction (HFrEF) happens when the heart’s left ventricular ejection fraction (LVEF) is 40% or less, a sign of a weak heart pump. The problem is that this sign of ...

Eko, a San Francisco-based startup developing artificial intelligence for heart disease screening, telehealth and remote patient monitoring, closed a $65 million Series C funding round, according to a ...

Eko’s smart stethoscopes have been used by U.S. physicians to automatically detect signs of atrial fibrillation and heart murmurs since its first FDA clearance arrived in 2020. A new regulatory OK ...

Last week, Eko Devices announced a new service that matches ECG and heart sound recordings with clinical data to help pinpoint novel drug-data combinations. The Silicon Valley startup is pitching the ...